New Developments in the Treatment Algorithm for Peripheral Neuropathic Pain

The role of botulinum toxin in management of pain: an evidence-based review

(2010) Erisela Qerama et al.   Current Opinion in Anesthesiology

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

(2010) N. Attal et al.   EUROPEAN JOURNAL OF NEUROLOGY

Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain

(2010) Wolfgang Schröder et al.   EUROPEAN JOURNAL OF PAIN

A Randomized, Controlled, Open-Label Study of the Long-Term Effects of NGX-4010, a High-Concentration Capsaicin Patch, on Epidermal Nerve Fiber Density and Sensory Function in Healthy Volunteers

(2010) William R. Kennedy et al.   JOURNAL OF PAIN

Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain

(2010) David M. Simpson et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Assessment and Treatment of Psychosocial Comorbidities in Patients With Neuropathic Pain

(2010) Dennis C. Turk et al.   MAYO CLINIC PROCEEDINGS

Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

(2010) Robert H. Dworkin et al.   MAYO CLINIC PROCEEDINGS

The burden of neuropathic pain: A systematic review and meta-analysis of health utilities

(2010) Alissa H. Doth et al.   PAIN

Treatment of Neuropathic Pain: An Overview of Recent Guidelines

(2009) Alec B. O'Connor et al.   AMERICAN JOURNAL OF MEDICINE

Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy

(2009) Ralf Baron et al.   CLINICAL DRUG INVESTIGATION

Anticonvulsants for Neuropathic Pain

(2009) Felicity Goodyear-Smith et al.   CLINICAL JOURNAL OF PAIN

Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain

(2009) James P. Wymer et al.   CLINICAL JOURNAL OF PAIN

Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study

(2009) Guy Hans et al.   CURRENT MEDICAL RESEARCH AND OPINION

Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial

(2009) R. Y. Yuan et al.   NEUROLOGY

A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster

(2009) Robert H. Dworkin et al.   PAIN

Spinal cord stimulation for failed back surgery syndrome: Outcomes in a workers’ compensation setting

(2009) Judith A. Turner et al.   PAIN

Spinal cord stimulation in a workers’ compensation population: How difficult it can be to interpret a clinical trial

(2009) Ajay D. Wasan   PAIN

Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain

(2008) Danièle Ranoux et al.   ANNALS OF NEUROLOGY

Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial

(2008) Aziz Shaibani et al.   EUROPEAN JOURNAL OF PAIN

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

(2008) Miroslav Backonja et al.   LANCET NEUROLOGY

Lacosamide

(2008) Emilio Perucca et al.   NATURE REVIEWS DRUG DISCOVERY

Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin

(2008) Parisa Gazerani et al.   PAIN

Pregabalin in the Treatment of Refractory Neuropathic Pain: Results of a 15-Month Open-Label Trial

(2008) Brett R. Stacey et al.   PAIN MEDICINE